Company / Depreciation & Amortization
Processa Pharmaceuticals, Inc. Depreciation & Amortization History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Depreciation & Amortization
$484
FY2022
5-year range
$484 / $71.0K
FY2018-FY2022
Trend
-94.3%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Depreciation & Amortization has declined for 3 consecutive years, from $71,029 in FY2015 to $484 in FY2022.
Based on SEC 10-K filings.
$484 in FY2022.
Improved from $60,251 to $484 over the past 6 years.
Depreciation & Amortization over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Processa Pharmaceuticals, Inc.'s depreciation & amortization has declined for 3 consecutive years.
- In FY2022, depreciation & amortization decreased 94.3% year-over-year.
- Peak depreciation & amortization was recorded in FY2015.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -4.39 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Depreciation & AmortizationValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $484 | -94.3% |
| FY2021 | $8.4K | -86.0% |
| FY2016 | $60.3K | -15.2% |
| FY2015 | $71.0K | +23.0% |
| FY2014 | $57.8K | +201.1% |
| FY2013 | $19.2K | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026